AKANTIOR

This brand name is authorized in Austria, Estonia, Finland, Lithuania.

Active ingredients

The drug AKANTIOR contains one active pharmaceutical ingredient (API):

1	Polihexanide UNII 322U039GMF - POLIHEXANIDE
	Polihexanide acts on both the active trophozoite and dormant cystal forms of Acanthamoeba. Polihexanide is a polycationic polymer composed of hexamethylene biguanide units and has a dual-targeted mechanism of action that involves disruption of Acanthamoeba cell membranes and DNA binding.
	Read more about Polihexanide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AKANTIOR Eye drops	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AX24		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AX Other antiinfectives
Discover more medicines within S01AX24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3091643, 3091654, 3091665
FI	Lääkealan turvallisuus- ja kehittämiskeskus	473490
LT	Valstybinė vaistų kontrolės tarnyba	1100813, 1100814, 1100815